{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:59:33Z","timestamp":1791575973374,"version":"4.3.4"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2019.00141","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T04:15:21Z","timestamp":1568952921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":223,"title":["Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities"],"prefix":"10.3389","volume":"6","author":[{"given":"Akshita","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Westein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be'eri","family":"Niego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph E.","family":"Hagemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"B1","first-page":"785","article-title":"Su di un nuovo elemento morfologico del sangue dei mammiferi e della sua importanza nella trombosi e nella coagulazione","volume":"17","author":"Bizzozero","year":"1881","journal-title":"L'Osservatore."},{"key":"B2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V46.3.321.321","article-title":"Platelet size in man","volume":"46","author":"Paulus","year":"1975","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood-2017-08-743229","article-title":"Mechanisms of platelet clearance and translation to improve platelet storage","volume":"131","author":"Quach","year":"2018","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1182\/blood-2006-07-028282","article-title":"Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation","volume":"109","author":"Maxwell","year":"2007","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03401.x","article-title":"Dynamics of platelet thrombus formation","volume":"7","author":"Jackson","year":"2009","journal-title":"J Thromb Haemost."},{"key":"B6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.thromres.2006.06.010","article-title":"Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy","volume":"119","author":"Kang","year":"2009","journal-title":"Thromb Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.thromres.2015.06.019","article-title":"Von Willebrand factor-A1 domain binds platelet glycoprotein Ib\u03b1 in multiple states with distinctive force-dependent dissociation kinetics","volume":"136","author":"Ju","year":"2015","journal-title":"Thromb Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-0-387-09789-3_5","article-title":"Platelet glycoprotein VI","volume":"640","author":"Jung","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/S0021-9258(19)34038-4","article-title":"The alpha 2 beta 1 integrin cell surface collagen receptor binds to the alpha 1 (I)-CB3 peptide of collagen","volume":"265","author":"Staatz","year":"1990","journal-title":"J Biol Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1538-7836.2004.00665.x","article-title":"The role of collagen in thrombosis and hemostasis","volume":"2","author":"Farndale","year":"2004","journal-title":"J Thromb Haemost."},{"key":"B11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/09537104.2018.1514109","article-title":"The platelet shape change: biophysical basis and physiological consequences","volume":"30","author":"Moskalensky","year":"2019","journal-title":"Platelets."},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2141.1975.tb01860.x","article-title":"The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation","volume":"30","author":"Macfarlane","year":"1975","journal-title":"Br J Haematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0268-960X(93)90024-X","article-title":"Platelet \u03b1-granules","volume":"7","author":"Harrison","year":"1993","journal-title":"Blood Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/j.1538-7836.2007.02537.x","article-title":"Platelet integrin alpha(IIb)beta(3): activation mechanisms","volume":"5","author":"Ma","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/09537109976077","article-title":"Binding of polymerizing fibrin to integrin alpha IIb beta3 on chymotrypsin-treated rabbit platelets decreases phosphatidylinositol 4,5-bisphosphate and increases cytoskeletal actin","volume":"10","author":"Vickers","year":"1999","journal-title":"Platelets"},{"key":"B18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/0192623310389474","article-title":"Continuing education course #2: current understanding of hemostasis","volume":"39","author":"Gale","year":"2011","journal-title":"Toxicol Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4065\/84.1.43","article-title":"Secondary prevention of atherothrombotic events after ischemic stroke","volume":"84","author":"Adams","year":"2009","journal-title":"Mayo Clin Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3233\/CH-2012-1578","article-title":"Clinical importance of antiplatelet drugs in cardiovascular diseases","volume":"53","author":"Papp","year":"2013","journal-title":"Clin Hemorheol Microcirc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"27a","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","article-title":"Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology","volume":"30","author":"Kuliczkowski","year":"2009","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1160\/TH09-06-0418","article-title":"Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb Haemost."},{"key":"B24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/07853890.2011.582137","article-title":"Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention","volume":"43","author":"Di Minno","year":"2011","journal-title":"Ann Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF03086244","article-title":"In search of a better platelet ADP-receptor blocker","volume":"17","author":"Verheugt","year":"2009","journal-title":"Neth Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"h7025","DOI":"10.1136\/bmj.h7025","article-title":"Newer antiplatelet agents in acute coronary syndrome","volume":"352","author":"Ferro","year":"2016","journal-title":"BMJ."},{"key":"B27","first-page":"1441","article-title":"Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality","volume":"163","author":"Paradiso-Hardy","year":"2000","journal-title":"Can Med Assoc J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ehj.2004.02.005","article-title":"Are we making efficient use of clopidogrel?","volume":"25","author":"Kastrati","year":"2004","journal-title":"Eur Heart J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"I19","DOI":"10.1093\/eurheartj\/sun036","article-title":"Benefits and risks with antiplatelet therapy: how great a problem is bleeding?","volume":"10","author":"Husted","year":"2008","journal-title":"Eur Heart J Suppl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11095-010-0209-4","article-title":"Old and new molecular mechanisms associated with platelet resistance to antithrombotics","volume":"27","author":"Farre","year":"2010","journal-title":"Pharm Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCINTERVENTIONS.109.919001","article-title":"Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation","volume":"3","author":"Tsai Thomas","year":"2010","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"234s","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the seventh ACCP Conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest."},{"key":"B36","first-page":"e57","article-title":"Bleeding complications associated with glycoprotein IIb\/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention","volume":"15","author":"Germing","year":"2010","journal-title":"Exp Clin Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jacc.2016.03.512","article-title":"Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice Guidelines","volume":"68","author":"Bittl","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/heartjnl-2016-309871","article-title":"Duration of dual antiplatelet therapy in acute coronary syndrome","volume":"103","author":"Wilson","year":"2017","journal-title":"Heart."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"H1787","DOI":"10.1152\/ajpheart.1993.265.5.H1787","article-title":"Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis","volume":"265","author":"Strony","year":"1993","journal-title":"Am J Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"FSO30","DOI":"10.4155\/fso.15.28","article-title":"The impact of blood shear rate on arterial thrombus formation","volume":"1","author":"Sakariassen","year":"2015","journal-title":"Future Sci OA."},{"key":"B48","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"Kroll","year":"1996","journal-title":"Blood."},{"key":"B49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1055\/s-0038-1661576","article-title":"Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-report\u2013subcommittee on rheology of the international committee on thrombosis and haemostasis","volume":"55","author":"Goldsmith","year":"1986","journal-title":"Thromb Haemost."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(82)90050-2","article-title":"Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions","volume":"2","author":"Livio","year":"1982","journal-title":"Lancet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.RES.43.5.738","article-title":"The distribution of blood rheological parameters in the microvasculature of cat mesentery","volume":"43","author":"Lipowsky","year":"1978","journal-title":"Circ Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"H1005","DOI":"10.1152\/ajpheart.1989.257.3.H1005","article-title":"Robin Fahraeus: evolution of his concepts in cardiovascular physiology","volume":"257","author":"Goldsmith","year":"1989","journal-title":"Am J Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/BF02368455","article-title":"The effect of flow and mass transport in thrombogenesis","volume":"18","author":"Basmadjian","year":"1990","journal-title":"Ann Biomed Eng."},{"key":"B54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/BIR-15061","article-title":"Role of fluid shear stress in regulating VWF structure, function and related blood disorders","volume":"52","author":"Gogia","year":"2015","journal-title":"Biorheology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/14796678.3.2.193","article-title":"Thrombus formation on apex of arterial stenoses: the need for a fluid high shear stenosis diagnostic device","volume":"3","author":"Sakariassen","year":"2007","journal-title":"Future Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood.V99.1.159","article-title":"Shear-dependent tether formation during platelet translocation on von Willebrand factor","volume":"99","author":"Dopheide","year":"2002","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1172\/JCI115124","article-title":"The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress","volume":"87","author":"Ikeda","year":"1991","journal-title":"J Clin Invest."},{"key":"B59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI7569","article-title":"A revised model of platelet aggregation","volume":"105","author":"Kulkarni","year":"2000","journal-title":"J Clin Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/beha.2001.0133","article-title":"Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation","volume":"14","author":"Ruggeri","year":"2001","journal-title":"Best Pract Res Clin Haematol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/blood-2002-05-1550","article-title":"Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension","volume":"101","author":"Shankaran","year":"2003","journal-title":"Blood."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1538-7836.2008.02991.x","article-title":"Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions","volume":"6","author":"Li","year":"2008","journal-title":"J Thromb Haemost."},{"key":"B64","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/1076029616675969","article-title":"von Willebrand disease: a concise review and update for the practicing physician","volume":"23","author":"Swami","year":"2017","journal-title":"Clin Appl Thromb Hemost."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.722827","article-title":"Von Willebrand factor in cardiovascular disease","volume":"117","author":"Spiel Alexander","year":"2008","journal-title":"Circulation."},{"key":"B66","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3324\/haematol.2008.003178","article-title":"Platelet receptors and signaling in the dynamics of thrombus formation","volume":"94","author":"Rivera","year":"2009","journal-title":"Haematologica."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.108.792986","article-title":"Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease","volume":"118","author":"Frankel David","year":"2008","journal-title":"Circulation."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","article-title":"von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population","volume":"10","author":"Van Loon","year":"2012","journal-title":"J Thromb Haemost."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.14670\/HH-24.1391","article-title":"Critical role of von Willebrand factor and platelet interaction in venous thromboembolism","volume":"24","author":"Takahashi","year":"2009","journal-title":"Histol Histopathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1063\/1.1681018","article-title":"Coil-stretch transition of dilute flexible polymers under ultrahigh velocity gradients","volume":"60","author":"De Gennes","year":"1974","journal-title":"J Chem Phys."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1126\/science.283.5408.1724","article-title":"Single-polymer dynamics in steady shear flow","volume":"283","author":"Smith","year":"1999","journal-title":"Science."},{"key":"B73","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1538-7836.2005.01209.x","article-title":"The von Willebrand factor self-association is modulated by a multiple domain interaction","volume":"3","author":"Ulrichts","year":"2005","journal-title":"J Thromb Haemost."},{"key":"B74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1182\/blood.V95.1.164","article-title":"Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation","volume":"95","author":"De Luca","year":"2000","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2010.07.002","article-title":"The effect of shear stress on protein conformation: physical forces operating on biochemical systems: the case of von Willebrand factor","volume":"153","author":"Di Stasio","year":"2010","journal-title":"Biophys Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1103\/PhysRevLett.84.4769","article-title":"Dynamics of a tethered polymer in shear flow","volume":"84","author":"Doyle","year":"2000","journal-title":"Phys Rev Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"138101","DOI":"10.1103\/PhysRevLett.97.138101","article-title":"Shear-flow-induced unfolding of polymeric globules","volume":"97","author":"Alexander-Katz","year":"2006","journal-title":"Phys Rev Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood."},{"key":"B79","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2006-04-011551","article-title":"Activation-independent platelet adhesion and aggregation under elevated shear stress","volume":"108","author":"Ruggeri","year":"2006","journal-title":"Blood."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science."},{"key":"B82","doi-asserted-by":"publisher","first-page":"L35","DOI":"10.1016\/j.bpj.2010.01.032","article-title":"Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates","volume":"98","author":"Sing","year":"2010","journal-title":"Biophys J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41467-017-00230-2","article-title":"Flow-induced elongation of von Willebrand factor precedes tension-dependent activation","volume":"8","author":"Fu","year":"2017","journal-title":"Nat Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.bpj.2009.12.4324","article-title":"Unfolding the A2 domain of von Willebrand factor with the optical trap","volume":"98","author":"Ying","year":"2010","journal-title":"Biophys J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1073\/pnas.1121261109","article-title":"Calcium stabilizes the von Willebrand factor A2 domain by promoting refolding","volume":"109","author":"Xu","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1182\/blood-2005-02-0618","article-title":"Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress","volume":"107","author":"Reininger","year":"2006","journal-title":"Blood."},{"key":"B88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5482\/HAMO-14-12-0081","article-title":"Interaction of von Willebrand factor with platelets and the vessel wall","volume":"35","author":"Ruggeri","year":"2015","journal-title":"Hamostaseologie."},{"key":"B89","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/10739680802651477","article-title":"Platelet adhesion under flow","volume":"16","author":"Ruggeri","year":"2009","journal-title":"Microcirculation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"11144","DOI":"10.1021\/bi00160a027","article-title":"Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin","volume":"31","author":"Berndt","year":"1992","journal-title":"Biochemistry."},{"key":"B91","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1182\/blood.V97.1.162","article-title":"Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions","volume":"97","author":"Dong","year":"2001","journal-title":"Blood."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1074\/jbc.274.5.3033","article-title":"Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow","volume":"274","author":"Mazzucato","year":"1999","journal-title":"J Biol Chem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"16900","DOI":"10.1073\/pnas.0608207103","article-title":"The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis","volume":"103","author":"Bergmeier","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B94","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-2007-1000387","article-title":"Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology","volume":"21","author":"Clemetson","year":"1995","journal-title":"Semin Thromb Hemost."},{"key":"B95","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1182\/blood-2011-05-356253","article-title":"Quaternary organization of GPIb-IX complex and insights into Bernard-Soulier syndrome revealed by the structures of GPIb\u03b2 and a GPIb\u03b2\/GPIX chimera","volume":"118","author":"Mcewan","year":"2011","journal-title":"Blood."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood-2005-10-3964","article-title":"The structure of the GPIb-filamin A complex","volume":"107","author":"Nakamura","year":"2006","journal-title":"Blood."},{"key":"B97","first-page":"173","article-title":"Platelet polymorphism and coronary artery disease","volume":"95","author":"Christiaens","year":"2002","journal-title":"Arch Mal Coeur Vaiss."},{"key":"B98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00210-003-0828-y","article-title":"Role of platelet glycoprotein polymorphisms in cardiovascular diseases","volume":"369","author":"Meisel","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science."},{"key":"B100","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/prot.21679","article-title":"Electrostatic rate enhancement and transient complex of protein-protein association","volume":"71","author":"Alsallaq","year":"2008","journal-title":"Proteins."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1172\/JCI35754","article-title":"Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF","volume":"118","author":"Yago","year":"2008","journal-title":"J Clin Invest."},{"key":"B102","doi-asserted-by":"publisher","first-page":"32289","DOI":"10.1074\/jbc.M113.504001","article-title":"The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibalpha","volume":"288","author":"Ju","year":"2013","journal-title":"J Biol Chem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nature09295","article-title":"A mechanically stabilized receptor\u2013ligand flex-bond important in the vasculature","volume":"466","author":"Kim","year":"2010","journal-title":"Nature."},{"key":"B104","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1182\/blood-2014-07-589507","article-title":"Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex","volume":"125","author":"Zhang","year":"2015","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1182\/blood.V99.1.145","article-title":"Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib\u03b1 using canine\u2013human chimeras","volume":"1","author":"Shen","year":"2002","journal-title":"Blood."},{"key":"B106","doi-asserted-by":"publisher","first-page":"26419","DOI":"10.1074\/jbc.M604296200","article-title":"Leucine-rich repeats 2-4 (Leu60-Glu128) of platelet glycoprotein Ibalpha regulate shear-dependent cell adhesion to von Willebrand factor","volume":"281","author":"Shen","year":"2006","journal-title":"J Biol Chem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.bpj.2015.08.050","article-title":"Force-induced unfolding of leucine-rich repeats of glycoprotein ib\u03b1 strengthens ligand interaction","volume":"109","author":"Ju","year":"2015","journal-title":"Biophys J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e15447","DOI":"10.7554\/eLife.15447","article-title":"Cooperative unfolding of distinctive mechanoreceptor domains transduces force into signals","volume":"5","author":"Ju","year":"2016","journal-title":"Elife."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1074\/jbc.M110070200","article-title":"Distinct glycoprotein Ib\/V\/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow","volume":"277","author":"Nesbitt","year":"2002","journal-title":"J Biol Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1182\/blood-2005-01-0440","article-title":"A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications","volume":"106","author":"Dai","year":"2005","journal-title":"Blood."},{"key":"B111","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41563-019-0323-6","article-title":"An integrin \u03b1IIb\u03b23 intermediate affinity state mediates biomechanical platelet aggregation","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Mater."},{"key":"B112","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet aggregation","volume":"109","author":"Jackson","year":"2007","journal-title":"Blood."},{"key":"B113","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ncpcardio0298","article-title":"The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications","volume":"2","author":"Slager","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0021-9290(73)90012-2","article-title":"Flow characteristics in models of arterial stenoses. II. Unsteady flow","volume":"6","author":"Young","year":"1973","journal-title":"J Biomech."},{"key":"B115","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00047.2009","article-title":"Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives","volume":"91","author":"Chiu","year":"2011","journal-title":"Physiol Rev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nm.1955","article-title":"A shear gradient-dependent platelet aggregation mechanism drives thrombus formation","volume":"15","author":"Nesbitt","year":"2009","journal-title":"Nat Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s10439-010-9936-2","article-title":"High-shear stress sensitizes platelets to subsequent low-shear conditions","volume":"38","author":"Sheriff","year":"2010","journal-title":"Ann Biomed Eng."},{"key":"B119","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.actbio.2018.04.002","article-title":"Effects of upstream shear forces on priming of platelets for downstream adhesion and activation","volume":"73","author":"Rahman","year":"2018","journal-title":"Acta Biomater."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1073\/pnas.1209905110","article-title":"Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner","volume":"110","author":"Westein","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B121","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/0002-9343(62)90243-7","article-title":"Factors influencing thrombus formation in vivo","volume":"33","author":"Mustard","year":"1962","journal-title":"Am J Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/cvr\/cvs217","article-title":"Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions","volume":"96","author":"Wentzel","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mvr.2013.08.008","article-title":"Hemodynamic features and platelet aggregation in a stenosed microchannel","volume":"90","author":"Ha","year":"2013","journal-title":"Microvasc Res."},{"key":"B124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V82.2.505.505","article-title":"Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release","volume":"82","author":"Rinder","year":"1993","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1055\/s-0038-1650374","article-title":"Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow","volume":"75","author":"Barstad","year":"1996","journal-title":"Thromb Haemost."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1161\/01.CIR.93.6.1201","article-title":"Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries","volume":"93","author":"Maalej","year":"1996","journal-title":"Circulation"},{"key":"B127","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V53.2.244.244","article-title":"Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium","volume":"53","author":"Weiss","year":"1979","journal-title":"Blood"},{"key":"B128","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jacc.2006.03.053","article-title":"Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation","volume":"48","author":"Borgdorff","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.bjp.0701354","article-title":"Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor","volume":"122","author":"Kageyama","year":"1997","journal-title":"Br J Pharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/01.ATV.19.4.877","article-title":"AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes","volume":"19","author":"Eto","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1161\/01.ATV.20.10.2303","article-title":"Anti-human von Willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs","volume":"20","author":"Kageyama","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/hq0102.101520","article-title":"Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys","volume":"22","author":"Kageyama","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0014-2999(02)01590-X","article-title":"Effect of a humanized monoclonal antibody to von Willebrand factor in a canine model of coronary arterial thrombosis","volume":"443","author":"Kageyama","year":"2002","journal-title":"Eur J Pharmacol."},{"key":"B134","article-title":"A humanised monoclonal antibody against VWF A1 domain inhibits VWF: RiCof activity and platelet adhesion in human volunteers","author":"Machin","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1538-7836.2009.03459.x","article-title":"Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779","volume":"7","author":"Diener","year":"2009","journal-title":"J Thromb Haemost."},{"key":"B136","unstructured":"FDA Approved Caplacizumab-yhdp2019"},{"key":"B137","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb Haemost."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke"},{"key":"B139","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/ATVBAHA.111.237529","article-title":"ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesion","volume":"32","author":"Siller-Matula","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B140","first-page":"A15084","article-title":"Abstract 15084: safety and efficacy of anti-von Willebrand factor nanobody\u00ae ALX-0081 in stable angina patients undergoing percutaneous coronary intervention","volume":"122","author":"Bartunek","year":"2010","journal-title":"Circulation."},{"key":"B141","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1160\/TH10-12-0804","article-title":"The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention","volume":"106","author":"Loon","year":"2011","journal-title":"Thromb Haemost."},{"key":"B142","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med."},{"key":"B144","doi-asserted-by":"crossref","first-page":"LBA-1","DOI":"10.1182\/blood.V130.Suppl_1.LBA-1.LBA-1","article-title":"Results of the randomized, double-blind, placebo-controlled, phase 3 hercules study of caplacizumab in patients with acquired thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood."},{"key":"B145","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/heart.89.3.329","article-title":"Coronary angioplasty enhances platelet reactivity through von Willebrand factor release","volume":"89","author":"Gorog","year":"2003","journal-title":"Heart"},{"key":"B146","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MOH.0b013e328309ec62","article-title":"Current management of thrombotic thrombocytopenic purpura","volume":"15","author":"Kremer Hovinga","year":"2008","journal-title":"Curr Opin Hematol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1126\/science.1217815","article-title":"Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels","volume":"337","author":"Korin","year":"2012","journal-title":"Science."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1161\/STROKEAHA.115.011063","article-title":"Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion","volume":"46","author":"Marosfoi","year":"2015","journal-title":"Stroke"},{"key":"B149","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nnano.2012.84","article-title":"Shear-stress sensitive lenticular vesicles for targeted drug delivery","volume":"7","author":"Holme","year":"2012","journal-title":"Nat Nanotechnol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/jth.13666","article-title":"Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation","volume":"15","author":"Molloy","year":"2017","journal-title":"J Thromb Haemost."},{"key":"B151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ddr.21103","article-title":"Destination known: targeted drug delivery in atherosclerosis and thrombosis","author":"Westein","year":"2013","journal-title":"Drug Dev Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1001\/jamaneurol.2014.2886","article-title":"Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeuticsnanotherapeutics for flow-obstructed blood vesselsnanotherapeutics for flow-obstructed blood vessels","volume":"72","author":"Korin","year":"2015","journal-title":"JAMA Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.2174\/1381612822666160628081419","article-title":"Shear stress-sensitive carriers for localized drug delivery","volume":"22","author":"Xia","year":"2016","journal-title":"Curr Pharm Des."},{"key":"B154","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jbiomech.2016.11.015","article-title":"Shear targeted drug delivery to stenotic blood vessels","volume":"50","author":"Epshtein","year":"2017","journal-title":"J Biomech."},{"key":"B155","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1517\/17425247.2.3.465","article-title":"Liposomes in the treatment of inflammatory disorders","volume":"2","author":"Metselaar","year":"2005","journal-title":"Expert Opin Drug Deliv."},{"key":"B156","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1124\/mi.6.2.7","article-title":"Advanced drug delivery systems that target the vascular endothelium","volume":"6","author":"Ding","year":"2006","journal-title":"Mol Interv."},{"key":"B157","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front Pharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"20140459","DOI":"10.1098\/rsif.2014.0459","article-title":"Liposomes in tissue engineering and regenerative medicine","volume":"11","author":"Monteiro","year":"2014","journal-title":"J R Soc Interface"},{"key":"B159","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0014-5793(94)00484-6","article-title":"Membrane bending energy concept of vesicle- and cell-shapes and shape-transitions","volume":"346","author":"Sackmann","year":"1994","journal-title":"FEBS Lett."},{"key":"B160","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcis.2004.12.019","article-title":"Shear-induced permeation and fusion of lipid vesicles","volume":"287","author":"Bernard","year":"2005","journal-title":"J Colloid Interface Sci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1021\/bc200694t","article-title":"New method for site-specific modification of liposomes with proteins using sortase A-mediated transpeptidation","volume":"23","author":"Guo","year":"2012","journal-title":"Bioconjug Chem."},{"key":"B162","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nprot.2014.177","article-title":"Particle generation, functionalization and sortase A\u2013mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use","volume":"10","author":"Hagemeyer","year":"2014","journal-title":"Nat Protoc."},{"key":"B163","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejpb.2018.09.017","article-title":"Sortaggable liposomes: evaluation of reaction conditions for single-domain antibody conjugation by Sortase-A and targeting of CD11b+ myeloid cells","volume":"133","author":"W\u00f6ll","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"B164","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1055\/s-2007-994943","article-title":"New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy","volume":"25","author":"Bajaj","year":"1999","journal-title":"Semin Thromb Hemost."},{"key":"B165","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.thj.6200306","article-title":"Role of coagulation testing in predicting bleeding risk","volume":"4","author":"Chee","year":"2003","journal-title":"Hematol J."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1213\/ane.0b013e318168b367","article-title":"Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices","volume":"106","author":"Ganter","year":"2008","journal-title":"Anesth Analg."},{"key":"B167","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.thromres.2013.02.018","article-title":"A low-volume, single pass < em>in-vitro < \/em> system of high shear thrombosis in a stenosis","volume":"131","author":"Para","year":"2013","journal-title":"Thromb Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1038\/ncomms10176","article-title":"A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function","volume":"7","author":"Jain","year":"2016","journal-title":"Nat Commun."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Jin-Wook","year":"2010","journal-title":"Curr Pharm Des."},{"key":"B170","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol Rep"},{"key":"B173","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrd985","article-title":"Scientific and therapeutic advances in antiplatelet therapy","volume":"2","author":"Bhatt","year":"2003","journal-title":"Nat Rev Drug Discov."},{"key":"B174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic","year":"2002","journal-title":"BMJ."},{"key":"B175","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nbt0103-31","article-title":"The master mammal","volume":"21","author":"Sands","year":"2003","journal-title":"Nat Biotechnol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/ATVBAHA.111.244608","article-title":"Critical review of mouse models of venous thrombosis","volume":"32","author":"Diaz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.biophys.35.040405.102013","article-title":"Mechanotransduction involving multimodular proteins: converting force into biochemical signals","volume":"35","author":"Vogel","year":"2006","journal-title":"Annu Rev Biophys Biomol Struct."},{"key":"B178","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1091\/mbc.e17-04-0228","article-title":"Receptor-mediated cell mechanosensing","volume":"28","author":"Chen","year":"2017","journal-title":"Mol Biol Cell"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1055\/s-0038-1656133","article-title":"Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model","volume":"77","author":"Perkins","year":"1997","journal-title":"Thromb Haemost."},{"key":"B180","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/s-0037-1613600","article-title":"Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase","volume":"90","author":"Leach","year":"2003","journal-title":"Thromb Haemost."},{"key":"B181","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.plipres.2004.12.001","article-title":"Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release","volume":"44","author":"Andresen","year":"2005","journal-title":"Prog Lipid Res."},{"key":"B182","first-page":"340","article-title":"Review: nanoparticles in delivery of cardiovascular drugs","volume":"20","author":"Arayne","year":"2007","journal-title":"Pak J Pharm Sci."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T03:06:40Z","timestamp":1664420800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":182,"alternative-id":["10.3389\/fcvm.2019.00141"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2019.00141","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"article-number":"141"}}